AeroLeads people directory · profile

Rachel Tam Email & Phone Number

Senior Principal Clinical Biomarker Scientist - Clinical Biomarker Lead at Bristol Myers Squibb at Bristol Myers Squibb
Location: Lawrence, New Jersey, United States 7 work roles 4 schools
1 work email found @bms.com 2 phones found area 650 and 404 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 2 phones

Work email r****@bms.com
Direct phone (650) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Senior Principal Clinical Biomarker Scientist - Clinical Biomarker Lead at Bristol Myers Squibb
Location
Lawrence, New Jersey, United States

Who is Rachel Tam? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Rachel Tam is listed as Senior Principal Clinical Biomarker Scientist - Clinical Biomarker Lead at Bristol Myers Squibb at Bristol Myers Squibb, based in Lawrence, New Jersey, United States. AeroLeads shows a work email signal at bms.com, phone signal with area code 650, 404, and a matched LinkedIn profile for Rachel Tam.

Rachel Tam previously worked as Senior Principal Clinical Biomarker Scientist at Bristol Myers Squibb and Principal Clinical Biomarker Scientist at Bristol Myers Squibb. Rachel Tam holds Mini-Mba Biopharma Innovation from Rutgers Business School.

Company email context

Email format at Bristol Myers Squibb

This section adds company-level context without repeating Rachel Tam's masked contact details.

{first}.{last}@bms.com
86% confidence

AeroLeads found 1 current-domain work email signal for Rachel Tam. Compare company email patterns before reaching out.

Profile bio

About Rachel Tam

• Highly accomplished Cancer Scientist with 15 years of pharmaceutical/biotechnology industry experience from early drug development through commercialization• Proven expertise in circulating tumor DNA detection technology, cancer immunotherapy, pediatric cancer, cancer biology & drug discovery• I have consistent record of innovative contributions to translational sciences / development in oncology as evidenced by first/co-authored publications in top-tier journals and oral presentations in conferences• Committed to advancing scientific knowledge and improving patient outcomes. Seeking to leverage skills and experience to drive breakthrough discoveries to facilitate the advancement of personalized therapiesInvited speaker at:1. Sino-American Pharmaceutical Professionals Association (SAPA) Scientific Symposium 2024 in Rutgers Robert Wood Johnson Medical School, NJ. Date: April 20, 2024. 2. Select Bioscience 2019 Liquid Biopsies Conference in Coronado Island, CA on March 27-29, 20193. The 26th International Molecular Med Tri-Conference March 14-15, 2019. San Francisco USATopic: Ultra-sensitive mutational analysis in cell-free DNA by digital PCR and NGS technologies 4. The 4th qPCR & Digital PCR Congress at the 4Bio Summit. Sept 13-14, 2018, San Francisco USA5. The 24th International Molecular Med Tri-Conference Feb 19-24, 2017. San Francisco USATopic: Ultra-sensitive mutational analysis in cell-free DNA by digital PCR and NGS technologies 6. The 2nd qPCR and Digital PCR Congress – 11th-12th July 2016, Philadelphia, USATopic: Ultra-sensitive mutational analysis in cell-free DNA by Digital PCR7. Digital PCR Technologies and Tools for Precision Diagnostics Conference 2014Topic: Digital PCR for Detecting Rare Genomic Alterations which Enhances Sensitivity in Cell-Free DNADigital magazine interview:CIO Applications-Dec 29, 2017 (P.42): https://lnkd.in/ge88zep

Listed skills include Pcr, Drug Discovery, Immunohistochemistry, Tissue Culture, and 41 others.

Current workplace

Rachel Tam's current company

Company context helps verify the profile and gives searchers a useful next step.

Bristol Myers Squibb
Bristol Myers Squibb
Senior Principal Clinical Biomarker Scientist - Clinical Biomarker Lead at Bristol Myers Squibb
AeroLeads page
7 roles · 19 years

Rachel Tam work experience

A career timeline built from the work history available for this profile.

Senior Principal Clinical Biomarker Scientist

Current

Lawrence Township, Nj, Us

- Biomarker Lead of multiple BMS IO-based clinical trials, including late stage molecules (Nivolumab, Ipilimumab, Relatlimab, IDO1 inhibitor and combination)- Biomarker lead of Repotrectinib (Augtyro) pediatric/young adults ROS1+/NTRK+ solid tumors CARE study- Provides biomarker leadership in MSI-H & MSS Colorectal, Gastric and Pediatric cancer disease strategies - Responsible for developing the biomarker strategy and utilizing emerging diagnostics for the oncology pipeline across all stages of clinical development including regulatory submission - As a pediatric biomarker lead in Pediatric Center of Excellence (PCoE), I am responsible for leading pediatric biomarker strategies for > 20 different solid tumor/ Heme assets in the pipeline across different TRCs/ TM, delivering preclinical biomarker packages to aid iPSP/PIP/ waivers submissions to FDA/EMA. -Responsible for biomarker elements in clinical protocols, biomarker analysis plans, regulatory submissions, investigator meetings, advisory boards and publications- Lead forward and reverse translation research to gain further insights into potential mechanisms of response and resistance to cancer immunotherapy

Jun 2022 - Present

Principal Clinical Biomarker Scientist

Lawrence Township, Nj, Us

Jan 2021 - Jun 2022

Senior Scientific Researcher At Oncology Biomarker Development

South San Francisco, California, Us

• Biomarker team member in cancer immunology franchise focusing on multiple GI cancer and T cell bispecifics clinical trials• Co-biomarker lead for biomarker discovery, phase 1 clinical trials and diagnostic strategies in Pediatric cancer• Facilitate and develop cancer biomarker exploratory strategies and collaborations on Pediatric and adult cancers with academic institutions and hospitals • Develop outsourcing strategy and communication with CROs and BOMs for sample processing, assay implementation and validation• NGS technology evaluation on FFPE and cell-free DNA samples using Ion Torrent PGM/S5XL, Ion Chef and automated library preparation technology on Ampliseq cancer mutation hotspot panel and molecular-tagging NGS technology• NGS data analysis utilizing Integrative Genomics Viewer (IGV), Partek and other 'Omics' softwares• Digital gene expression analysis by Nanostring technologies• Designed, validated and executed the in-house 6-gene, 11-gene,13-gene and CRC-focused high-throughput mutation detection and copy number variation panels using Fluidigm microfluidics technology, supporting the vigorous pipeline from gRED• Supported the development of high-throughput Fluidigm methylation panel• Analyzed and QC clinical FFPE, fresh frozen, TMA, exosomal RNA and cfDNA samples on mutation panels to support Genentech's (gRED) vigorous pipelines• Digital PCR technology evaluation (Life technologies and Bio Rad ddPCR systems) for mutation detection/copy number analysis• HER2 droplet ddPCR copy number analysis on cfDNA clinical samples • Developed and validated the in-house gene expression panels (HPV, Epigenetics...etc) to support multiple clinical trials and research groups• Genome-wide Epigenetics (ChIP-PCR) studies, examining DNA binding proteins on cell lines • Presented scientific data both externally (AACR) and internally• Trained and mentored RAs on running in-house qPCR, ddPCR and NGS technologies and presentations

Feb 2011 - Dec 2020

Scientific Researcher Oncology Biomarker Development

South San Francisco, California, Us

• Macro-dissected tumour FFPE tissues from slides and perform de-paraffinazation• Isolated DNA and RNA from FFPE tissue sections• Documented and maintained the clinical/vendor procured samples database for the tissue core group.• Validated and ran the Angiogenesis gene expression panel for VEGF research group. Clinical, vendor procured and collaboration FFPE/fresh frozen samples were analyzed• Analyzed and QC gene expression data• Trained colleagues to perform de-paraffinazation, nucleic acid isolations and Fluidigm Biomark chip runs• Ordered lab supplies• Assisted with freezers reorganization

Jan 2010 - Feb 2011

Lab Manager

Sydney, New South Wales (Nsw), Au

Managed supervisor and students Accounting Research reagents and lab consumables ordering Trained users of tissue culture facilities, gel-doc systems, coulter counter technology and western blotting techniquesAssisted students with technical difficulties with their research projects Arranged meetings with other lab members and sales representatives

Jun 2003 - Jan 2005
4 education records

Rachel Tam education

Mini-Mba Biopharma Innovation

Rutgers Business School

Phd, Pharmacology

Unsw

Bsc (Hons), Pharmacology

Unsw

Bsc, Physiology And Pharmacology

The University Of Auckland
FAQ

Frequently asked questions about Rachel Tam

Quick answers generated from the profile data available on this page.

What company does Rachel Tam work for?

Rachel Tam works for Bristol Myers Squibb.

What is Rachel Tam's role at Bristol Myers Squibb?

Rachel Tam is listed as Senior Principal Clinical Biomarker Scientist - Clinical Biomarker Lead at Bristol Myers Squibb at Bristol Myers Squibb.

What is Rachel Tam's email address?

AeroLeads has found 1 work email signal at @bms.com for Rachel Tam at Bristol Myers Squibb.

What is Rachel Tam's phone number?

AeroLeads has found 2 phone signal(s) with area code 650, 404 for Rachel Tam at Bristol Myers Squibb.

Where is Rachel Tam based?

Rachel Tam is based in Lawrence, New Jersey, United States while working with Bristol Myers Squibb.

What companies has Rachel Tam worked for?

Rachel Tam has worked for Bristol Myers Squibb, Genentech, Inc., University Of California, San Francisco, Texas A & M University, and University Of New South Wales.

How can I contact Rachel Tam?

You can use AeroLeads to view verified contact signals for Rachel Tam at Bristol Myers Squibb, including work email, phone, and LinkedIn data when available.

What schools did Rachel Tam attend?

Rachel Tam holds Mini-Mba Biopharma Innovation from Rutgers Business School.

What skills is Rachel Tam known for?

Rachel Tam is listed with skills including Pcr, Drug Discovery, Immunohistochemistry, Tissue Culture, Western Blotting, Molecular Biology, Confocal Microscopy, and Qpcr.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.